|
|
||||
|
COVID-19 Non-Placebo Vaccine Positive Serum & Plasma In-stock now
Innovative Research is pleased to announce the availability of COVID-19 Non-Placebo Vaccine Positive samples as well confirmed negative samples that are designed for use in a wide range of research applications, including assay development. Please be aware that available stock will be sold on a first-come basis. You can email sales@innov-research.com to request a database of available samples that includes full details, including IgG antibody results. Available Products Include:
COVID-19 vaccine positive status has been confirmed via SARS-CoV-2 IgG antibody assay through negative pre- trial blood draw results and positive post booster tests. This plasma is suitable for use of vNT assay development, among other research applications. Supporting COVID-19 & Life Science Research Our SARS-CoV-2 IgG Seroconversion ELISA Kit is specific to the RBD of the spike protein, ensuring high sensitivity and specificity and is suitable for clinical/diagnostic applications. We also offer the Recombinant SARS-CoV-2 Spike Protein RBD. We also introduced our new Viral Transport Media (VTM) line and Synthetic Human Cerebrospinal Fluid (CSF) to help support ongoing research into COVID-19 and other life science applications.
We have recently seen increasing popularity among several of our products, and these continue to be available: |
||||
Innovative Research | 開始堤供COVID-19非安慰劑疫苗陽性血清和血漿!
2020.11.14
